GLP-1 agonists with basal insulin are a good treatment option in patients with type 2 diabetes
Metadata[+] Show full item record
Bottom line: A GLP-1 agonist and basal insulin combination offers a potential treatment option that improves glycemic control and reduces weight with no increased risk of hypoglycemia. The validity of this conclusion is limited by study heterogeneity and bias from open-label and industry-sponsored studies.
Evidence-based practice 18, no. 07 (2015): 4